Companies / Sarepta Therapeutics, Inc.

Sarepta Therapeutics, Inc.

Nasdaq: SRPTCIK 873303CAMBRIDGE, MAsarepta.com ↗

Financials · FY2025

Revenue$2.20B
Net income$-713.41M
Total debt$847.62M
Cash$571.15M
Diluted EPS$-7.13
Shares outstanding105.6M

Ownership

105.6M shares outstanding · as of Jul 31, 2026
0.92%Insiders
Ownership
Insiders0.92%969,668
10%+ / strategic20.97%22,148,755
Institutions77.39%81,743,073
Public float0.72%765,525

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 8

View all →
Insider% of sharesShares
Rodino-Klapac LouisePresident, R&D and Tech Ops
0.21%225,323
Behrens M KathleenDirector
0.20%214,357
Estepan Ian MichaelChief Operating Officer
0.19%201,983
Rothfuss CristinEVP, General Counsel
0.13%137,544
Wong Ryan Ho-YanChief Financial Officer
0.13%135,064
Nicaise ClaudeDirector
0.03%31,532
Connelly Deirdre PDirector
0.02%22,100
Mayo StephenDirector
<0.01%1,765

Institutional holders 357

View all →
HolderValue% of shares
BlackRock, Inc.$341.34M17.98%
Vanguard Group Inc$254.17M11.18%
State Street Corporation$160.22M8.44%
AQR Capital Management, LLC$138.63M6.09%
Two Sigma Investments, LP$99.95M4.35%
First Trust Advisors LP$89.99M3.92%
RA Capital Management, L.P.$84.92M3.69%
Erste Asset Management GmbH$58.73M2.58%
Aberdeen Group plc$48.45M2.13%
Two Sigma Advisers, LP$44.58M1.96%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jan 27, 2026Behrens M Kathleen
Director
OtherCommon Stock$144.0K-6K
-3.18%
197,482
0.19% of shares
low
Jan 29, 2026Nicaise Claude
Director
ExerciseCommon Stock$144.0K+11K
+37.75%
38,312
0.04% of shares
low
Jan 27, 2026Behrens M Kathleen
Director
ExerciseCommon Stock$144.0K+11K
+5.43%
203,976
0.19% of shares
low
Jan 29, 2026Nicaise Claude
Director
OtherCommon Stock$143.9K-7K
-17.70%
31,532
0.03% of shares
low
Mar 12, 2026Mayo Stephen
Director
SellCommon Stock$123.2K-7K
-80.40%
1,765
<0.01% of shares
medium
Feb 26, 2026Estepan Ian Michael
Executive
ExerciseCommon Stock$73.8K+5K
+2.75%
200,750
0.19% of shares
low
Mar 2, 2026Rodino-Klapac Louise
Executive
OtherCommon Stock$60.2K-4K
-1.60%
228,437
0.22% of shares
low
Mar 2, 2026Estepan Ian Michael
Executive
OtherCommon Stock$53.5K-3K
-1.58%
205,574
0.19% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
State Street CorporationPassive13G—8,916,103—
Vanguard Group IncPassive13G/A—0—
AQR Capital Management, LLCPassive13G———
BlackRock, Inc.Passive13G/A—13,232,652—

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
SRPT——803607100—